IMMUCELL CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.81 USD | +0.21% |
|
-11.58% | -5.50% |
| 15/05 | Transcript : ImmuCell Corporation, Q1 2024 Earnings Call, May 15, 2024 | |
| 09/04 | Immucell Corporation Reports Unaudited Sales Results for the Three Months and Twelve Months Ended March 31, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IMMUCELL CORPORATION | Other Biotechnology & Medical Research | +0.21% | -11.58% | -5.50% | -1.23% | -23.04% | 37.63M |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- ICCC Stock
- Charts ImmuCell Corporation
- Comparison Chart